Selective estrogen receptor modulators (SERMs): New alternatives for osteoarthritis?

Maturitas

Volumn 77, Issue 4, 2014, Pages 380-384

  Lugo, L ^a   Villalvilla, A ^a   Largo, R ^a   Herrero Beaumont, G ^a   Roman Blas, J A ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Estrogen receptors; Hormone therapy; Osteoarthritis; Selective estrogen receptor modulators

Indexed keywords

BAZEDOXIFENE; CARTILAGE OLIGOMERIC MATRIX PROTEIN; CENTCHROMAN; ESTROGEN RECEPTOR; LASOFOXIFENE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

ARTICULAR CARTILAGE; BONE DENSITY; BONE REMODELING; BONE TURNOVER; DRUG EFFECT; ESTROGEN THERAPY; HUMAN; IN VIVO STUDY; JOINT PROSTHESIS; MENOPAUSE; MUSCLE; NONHUMAN; OSTEOARTHRITIS; PHENOTYPE; POSTMENOPAUSE; PREVALENCE; REVIEW; SYNOVIUM; SYSTEMATIC REVIEW; TENDON; AGED; ANIMAL; CLINICAL TRIAL (TOPIC); DISEASE MODEL; FEMALE;

AGED; ANIMALS; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; OSTEOARTHRITIS; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 84896400334     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2014.01.016     Document Type: Review

References (38)

1. N.E. Lane, K. Brandt, G. Hawker, E. Peeva, E. Schreyer, and W. Tsuji et al. OARSI-FDA initiative: defining the disease state of osteoarthritis Osteoarthritis Cartil 19 2011 478 482
2. G. Herrero-Beaumont, J.A. Roman-Blas, S. Castañeda, and S.A. Jimenez Primary osteoarthritis no longer primary: three subsets with distinct etiological, clinical, and therapeutic characteristics Semin Arthritis Rheum 39 2009 71 80
3. J.A. Roman-Blas, S. Castañeda, R. Largo, and G. Herrero-Beaumont Osteoarthritis associated with estrogen deficiency Arthritis Res Ther 11 2009 241
4. B.M. De Klerk, D. Schiphof, F.P. Groeneveld, B.W. Koes, G.J. van Osch, and J.B. van Meurs et al. Limited evidence for a protective effect of unopposed oestrogen therapy for osteoarthritis of the hip: a systematic review Rheumatology (Oxford) 48 2009 104 112
5. M.C. Nevitt, S.R. Cummings, N.E. Lane, M.C. Hochberg, J.C. Scott, and A.R. Pressman et al. Association of estrogen replacement therapy with the risk of osteoarthritis of the hip in elderly white women. Study of osteoporotic fractures research group Arch Intern Med 156 1996 2073 2080
6. T.D. Spector, D. Nandra, D.J. Hart, and D.V. Doyle Is hormone replacement therapy protective for hand and knee osteoarthritis in women. The Chingford study Ann Rheum Dis 56 1997 432 444
7. M.T. Hannan, D.T. Felson, J.J. Anderson, A. Naimark, and W.B. Kannel Estrogen use and radiographic osteoarthritis of the knee in women: the Framingham Osteoarthritis Study Arthritis Rheum 33 1990 525 532
8. D.J. Hart, D.V. Doyle, and T.D. Spector Incidence and risk factors for radiographic knee osteoarthritis in middle-aged women: the Chingford Study Arthritis Rheum 42 1999 17 24
9. Y. Zhang, T.E. McAlindon, M.T. Hannan, C.E. Chaisson, R. Klein, and P.W. Wilson et al. Estrogen replacement therapy and worsening of radiographic knee osteoarthritis: the Framingham Study Arthritis Rheum 41 1998 1867 1873
10. D.J. Cirillo, R.B. Wallace, L. Wu, and R.A. Yood Effect of hormone therapy on risk of hip and knee joint replacement in the Women's Health Initiative Arthritis Rheum 54 2006 3194 3204
11. L.D. Carbone, M.C. Nevitt, K. Wildy, K.D. Barrow, F. Harris, and D. Felson et al. Health, aging and body composition study: the relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritis Arthritis Rheum 50 2004 3516 3525
12. B.L. Wise, J. Niu, Y. Zhang, D.T. Felson, L.A. Bradley, and N. Segal et al. The association of parity with osteoarthritis and knee replacement in the Multicenter Osteoarthritis Study Osteoarthritis Cartil 21 2013 1849 1854
13. B. Liu, A. Balkwill, C. Cooper, A. Roddam, A. Brown, V. Beral Million Women Study Collaborators Reproductive history, hormonal factors and the incidence of hip and knee replacement for osteoarthritis in middle-aged women Ann Rheum Dis 68 2009 115 1170
14. S.K. Seo, H.I. Yang, K.J. Lim, Y.E. Jeon, Y.S. Choi, and S. Cho et al. Changes in serum levels of cartilage oligomeric matrix protein after estrogen and alendronate therapy in postmenopausal women Gynecol Obstet Invest 74 2012 143 150
15. D. Prieto-Alhambra, M.K. Javaid, A. Judge, J. Maskell, C. Cooper, and N.K. Arden On behalf of the COASt Study Group. Hormone replacement therapy and mid-term implant survival following knee or hip arthroplasty for osteoarthritis: a population-based cohort study Ann Rheum Dis 2014 [Epub ahead of print], doi: 10.1136/annrheumdis-2013-204043
16. Y.H. Sniekers, H. Weinans, S.M. Bierma-Zeinstra, J.P. van Leeuwen, and G.J. van Osch Animal models for osteoarthritis: the effect of ovariectomy and estrogen treatment - a systematic approach Osteoarthritis Cartil 16 2008 533 541
17. S. Oestergaard, B.C. Sondergaard, P. Hoegh-Andersen, K. Henriksen, P. Qvist, and C. Christiansen et al. Effects of ovariectomy and estrogen therapy on type II collagen degradation and structural integrity of articular cartilage in rats: implications of the time of initiation Arthritis Rheum 54 2006 2441 2451
18. K.D. Ham, and C.S. Carlson Effects of estrogen replacement therapy on bone turnover in subchondral bone and epiphyseal metaphyseal cancellous bone of ovariectomized cynomolgus monkeys J Bone Miner Res 19 2004 823 829
19. E.J. Olson, B.R. Lindgren, and C.S. Carlson Effects of long-term estrogen replacement therapy on the prevalence and area of periarticular tibial osteophytes in surgically postmenopausal cynomolgus monkeys Bone 41 2007 282 289
20. E.J. Olson, B.R. Lindgren, and C.S. Carlson Effects of long-term estrogen replacement therapy on bone turnover in periarticular tibial osteophytes in surgically postmenopausal cynomolgus monkeys Bone 42 2008 907 913
21. Y.H. Sniekers, H. Weinans, G.J. van Osch, and J.P. van Leeuwen Oestrogen is important for maintenance of cartilage and subchondral bone in a murine model of knee osteoarthritis Arthritis Res Ther 12 2010 R182
22. T. Funck-Brentano, H. Lin, E. Hay, M.D. Ah Kioon, C. Schiltz, D. Hannouche, R. Nizard, F. Lioté, P. Orcel, M.C. de Vernejoul, and M.E. Cohen-Solal Targeting bone alleviates osteoarthritis in osteopenic mice and modulates cartilage catabolism PLoS One 7 3 2012 e33543
23. J.H. Yang, J.H. Kim, D.S. Lim, and K.J. Oh Effect of combined sex hormone replacement on bone/cartilage turnover in a murine model of osteoarthritis Clin Orthop Surg 4 2012 234 241
24. A. Yoshida, T. Morihara, K. Matsuda, H. Sakamoto, Y. Arai, and Y. Kida et al. Immunohistochemical analysis of the effects of estrogen on intraarticular neurogenic inflammation in a rat anterior cruciate ligament transection model of osteoarthritis Connect Tissue Res 53 2012 197 206
25. X.D. Wang, X.X. Kou, Z. Meng, R.Y. Bi, Y. Liu, and J.N. Zhang et al. Estrogen aggravates iodoacetate-induced temporomandibular joint osteoarthritis J Dent Res 92 2013 918 924
26. S. Christgau, L.B. Tankó, P.A. Cloos, U. Mouritzen, C. Christiansen, and J.M. Delaissé et al. Suppression of elevated cartilage turnover in postmenopausal women and in ovariectomized rats by estrogen and a selective estrogen-receptor modulator (SERM) Menopause 11 2004 508 518
27. M.A. Karsdal, A.C. Bay-Jensen, K. Henriksen, and C. Christiansen The pathogenesis of osteoarthritis involves bone, cartilage and synovial inflammation: may estrogen be a magic bullet Menopause Int 18 2012 139 146
28. T. Fujita, Y. Fujii, H. Munezane, M. Ohue, and Y. Takagi Analgesic effect of raloxifene on back and knee pain in postmenopausal women with osteoporosis and/or osteoarthritis J Bone Miner Metab 28 2010 477 484
29. I.A. Rosner, C.J. Malemud, V.M. Goldberg, R.S. Papay, L. Getzy, and R.W. Moskowitz Pathologic and metabolic responses of experimental osteoarthritis to estradiol and an estradiol antagonist Clin Orthop Relat Res 1982 280 286
30. I.A. Rosner, B.A. Boja, V.M. Goldberg, and R.W. Moskowitz Tamoxifen therapy in experimental osteoarthritis Curr Ther Res 34 1983 409 414
31. C.L. Tsai, and T.K. Liu Inhibition of estradiol-induced early osteoarthritic changes by tamoxifen Life Sci 50 1992 1943 1951
32. C. Colombo, M. Butler, L. Hickman, M. Selwyn, J. Chart, and B. Steinetz A new model of osteoarthritis in rabbits II. Evaluation of anti-osteoarthritic effects of selected antirheumatic drugs administered systemically Arthritis Rheum 26 1983 1132 1139
33. P. Høegh-Andersen, L.B. Tankó, T.L. Andersen, C.V. Lundberg, J.A. Mo, and A.M. Heegaard et al. Ovariectomized rats as a model of postmenopausal osteoarthritis: validation and application Arthritis Res Ther 6 2004 R169 R180
34. A. Kavas, S.T. Cagatay, S. Banerjee, D. Keskin, and A. Tezcaner Potential of raloxifene in reversing osteoarthritis-like alterations in rat chondrocytes: an in vitro model study J Biosci 38 2013 135 147
35. L. Tinti, S. Niccolini, A. Lamboglia, N.A. Pascarelli, R. Cervone, and A. Fioravanti Raloxifene protects cultured human chondrocytes from IL-1β induced damage: a biochemical and morphological study Eur J Pharmacol 670 2011 67 73
36. Y. Hattori, T. Kojima, D. Kato, H. Matsubara, M. Takigawa, and N. Ishiguro A selective estrogen receptor modulator inhibits tumor necrosis factor-α-induced apoptosis through the ERK1/2 signaling pathway in human chondrocytes Biochem Biophys Res Commun 421 2012 418 424
37. J.A. Roman-Blas, S. Castañeda, R. Largo, W.F. Lems, and G. Herrero-Beaumont An OA phenotype may obtain major benefit from bone-acting agents Semin Arthritis Rheum 43 2014 421 428
38. G. Herrero-Beaumont, and J.A. Roman-Blas Osteoarthritis: osteoporotic OA: a reasonable target for bone-acting agents Nat Rev Rheumatol 9 2013 448 450